Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156922 | SCV000206643 | uncertain significance | not specified | 2014-11-28 | criteria provided, single submitter | clinical testing | The p.Tyr534Cys variant in USH2A has not been previously reported in individuals with hearing loss but was reported in 1/11540 Latino chromosomes by the Exome A ggregation Consortium (http://exac.broadinstitute.org). Although this variant ha s been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that the p.Tyr534Cys variant may impact the protein, though this informa tion is not predictive enough to determine pathogenicity. In summary, the clinic al significance of the p.Tyr534Cys variant is uncertain. |
Counsyl | RCV000669395 | SCV000794143 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453205 | SCV004182519 | uncertain significance | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826857 | SCV004182520 | uncertain significance | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826857 | SCV002093979 | uncertain significance | Usher syndrome type 2A | 2020-02-03 | no assertion criteria provided | clinical testing |